Morgan Stanley analyst Michael Cyprys lowered the firm’s price target on Hamilton Lane (HLNE) to $141 from $159 and keeps an Equal Weight rating on the shares. Into Q1 results, the firm lowered EPS estimates 9% on average and is 1% ahead of consensus on a median basis across its alternative asset manager coverage, the analyst tells investors in a preview for the group.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HLNE:
- Qualcomm downgraded, Okta upgraded: Wall Street’s top analyst calls
- Hamilton Lane upgraded to Overweight from Neutral at JPMorgan
- Hamilton Lane price target lowered to $171 from $230 at Oppenheimer
- Hamilton Lane price target lowered to $120 from $170 at Keefe Bruyette
- Hamilton Lane price target lowered to $118 from $148 at BMO Capital